Your Article Summary
See Latest ArticlesDetection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma
Human Pathology, 06/11/09
Santarpia L et al. - The effect of this mutation on the structural formation of the protein is highlighted. The results confirm the infrequency of BRAF (V600E) mutation in FVPTC and identify a novel (A598V) mutation of this gene.
Related Articles
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Relevance Score: 69%
Papillary Carcinoma Located in the Thyroid Isthmus
World Journal of Surgery, 12/02/09
Relevance Score: 68%
S100A8 and S100A9 Expression Is a Crucial Factor for Dedifferentiation in Thyroid Carcinoma
Anticancer Research, 11/11/09
Relevance Score: 68%
Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09
Relevance Score: 68%
Prophylactic Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma
Archives of Otolaryngology, 11/24/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09
Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by deltaNp73 in Neuroblastoma
Molecular Cancer Research, 12/04/09
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression
Virchows Archiv, 12/04/09
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimotos thyroiditis
Histopathology, 12/04/09
Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference
Histopathology, 12/04/09
Clinical inquiry: What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
The Journal of Family Practice, 12/03/09